Related Experiment Video
Updated: Aug 29, 2026
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Type-specific enzyme immunoassay for detection of pneumococcal capsular polysaccharide antigens in nasopharyngeal
K S Lankinen1, S Rintamäki, R Syrjänen
1Department of Microbiology, KTL, National Public Health Institute, P.O. Box 310, FIN-90101, Oulu, Finland. kari.lankinen@welho.com
Insights
A new enzyme immunoassay (EIA) method effectively identifies key pneumococcal capsular polysaccharides in respiratory samples. This sensitive and type-specific assay aids in studying pneumococcal carriage, particularly for vaccine-targeted serotypes.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Streptococcus pneumoniae causes significant respiratory illness.
- Accurate identification of pneumococcal serotypes is crucial for vaccine development and epidemiological studies.
- Existing methods for pneumococcal detection can be labor-intensive or lack specificity.
Purpose of the Study:
- To develop and validate a novel competitive enzyme immunoassay (EIA) for detecting specific pneumococcal capsular polysaccharides.
- To assess the sensitivity and type-specificity of the developed EIA method.
- To evaluate the applicability of the EIA for identifying pneumococcus in nasopharyngeal samples.
Main Methods:
- Development of a competitive enzyme immunoassay (EIA) targeting pneumococcal capsular polysaccharides.
- Testing EIA sensitivity with purified polysaccharide antigens (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F).
- Validation of the EIA using 100 nasopharyngeal samples (NPS) after enrichment culture.
Main Results:
- EIA sensitivity for purified antigens ranged from 5 to 100 ng/ml.
- The assay demonstrated high sensitivity (nearly 100%) compared to routine culture in NPS samples.
- The method was largely type-specific, with a minor cross-reactivity observed between 6B and 6A serotypes.
Conclusions:
- The developed competitive EIA is a sensitive and type-specific method for detecting pneumococcal capsular polysaccharides.
- This EIA method is suitable for identifying pneumococcus in carriage studies, particularly for vaccine-relevant serotypes.
- The assay shows promise for epidemiological surveillance of Streptococcus pneumoniae.
Abstract:
We developed a new competitive EIA method for the demonstration of pneumococcal capsular polysaccharides from respiratory samples. The pediatric types 4, 6B, 9V, 14, 18C, 19F and 23F were selected for this study, because these capsular polysaccharides were included in the first heptavalent pneumococcal conjugate vaccines, which were used in the Finnish Otitis Media Vaccine Trial. Sensitivity of the EIA tests for purified polysaccharide antigens varied between 5 and 100 ng/ml, depending on the type. The assays performed well in 100 nasopharyngeal samples (NPS) samples processed through an enrichment culture, with an almost 100% sensitivity compared with routine culture. The method appeared type-specific, except that EIA for 6B capsule also detected 6A. The method is applicable for type-specific identification of pneumococcus in carriage studies.
Related Concept Videos
01:33Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
01:14Atypical Pneumonia